Home/Learn/Signs you're losing muscle on a GLP-1

GLP-1 & muscle

Signs you're losing muscle, not just fat, on a GLP-1

The scale drops, but is it fat or muscle? Here are the honest at-home signs, why the scale and even a DXA scan can mislead you, and the one signal actually worth tracking.

Key takeaways

  • Part of GLP-1 weight loss is lean mass: reviews place it at roughly 15 to 40 percent of total weight lost,1 and about 26 percent in the best-measured tirzepatide trial.2
  • The scale cannot tell fat from muscle, and even a DXA "lean mass" reading includes water and organ tissue, so no single number is definitive.
  • Short-term trials often showed preserved grip strength even as lean mass fell; longer-term data in older adults is more cautious.3
  • The most useful home signal is your own strength, tracked over time on a few basic movements.
  • If the signs point one way, the fix is resistance training and enough protein, not stopping weight loss.45

If you are on a GLP-1 medication like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), the weight is probably coming off. The harder question is what kind of weight. Some of what you lose is fat, and some is lean mass, the skeletal muscle that keeps you strong and mobile. Across the trials that measured body composition, reviews place lean mass at roughly 15 to 40 percent of total weight lost.1 In the best-measured trial, the SURMOUNT-1 DXA substudy, about 26 percent of the weight lost on tirzepatide was lean tissue.2

None of this is a reason to stop your medication. It is a reason to know what losing muscle actually feels and looks like, so you can adjust before it adds up. This article walks through the honest at-home signs, explains why the scale and even a DXA scan can mislead you, and points to the one signal worth tracking. It is educational, not a diagnosis.

Why the scale can't answer this

The scale weighs everything at once: fat, muscle, water, food, and waste. It cannot tell you which tissue left. That matters because rapid weight loss of any kind pulls from lean tissue as well as fat, and GLP-1 medications produce fast, large losses. Semaglutide drove about 14.9 percent mean weight loss over 68 weeks in STEP 1,6 and tirzepatide reached about 20.9 percent at its highest dose in SURMOUNT-1.7 A quick drop on the scale is not, by itself, evidence that the loss is "all fat." The composition depends heavily on what else you are doing, especially whether you are eating enough protein and loading your muscles.

The everyday signs worth watching

No one of these confirms muscle loss on its own. Read them together, over weeks rather than days, as prompts to look closer.

  • Strength dropping on the same movements. The most telling sign is when familiar tasks get harder. The groceries feel heavier, the dumbbell you used a month ago is a grind, standing up from a low chair takes more effort. If your performance on the same movements is sliding while your body weight is falling, muscle is a plausible reason.
  • Feeling weaker or more fatigued than the diet alone explains. Persistent weakness, breathlessness on stairs you used to climb easily, or a general loss of physical capacity can accompany lean-mass loss. These symptoms have many other causes, including simply eating much less, so treat them as a reason to look closer, not a verdict.
  • A fast scale drop paired with low protein and no training. The combination matters more than any single number. A very fast drop, while you are eating little protein and doing no resistance training, is the setup most likely to cost you muscle. In one cross-sectional study, only 43 percent of GLP-1 users met even a modest protein minimum,8 so under-eating protein is the common case, not the exception.
  • A looser but "softer" look. Losing fat usually makes you look leaner and more defined. If clothes are looser but you look softer or flatter rather than tighter, some of the loss may be the muscle underneath that gave your frame its shape. This is a subjective read, not a measurement, but paired with falling strength it is worth noting.

Why even a DXA "lean mass" number is imperfect

You might assume a body-composition scan settles the question. It helps, but it is not the last word. "Lean mass" on a DXA scan includes water, organ tissue, and glycogen-bound water, not just contractile muscle, so a drop in the number is an imperfect proxy for how strong you actually are. This cuts both ways. Several short-to-mid-term GLP-1 trials found that grip strength held steady even as lean mass fell, which is reassuring in the near term. But longer-term research is more cautious: a 2026 analysis in the British Journal of Pharmacology reported reductions in muscle strength, including handgrip strength, a standard sarcopenia marker, among older adults on GLP-1 therapy.3 The practical reading is not to panic over a single lean-mass number, and not to assume you are fine just because you felt the same at month three.

The fix, in full

The complete, fully-cited protocol

Our 30-page handbook turns these signs into an exact plan: how to track your strength, two training routines plus a bodyweight-only option, a protein strategy built for a suppressed appetite, and what to measure over time. Every claim is cited to the research.

Get the full handbook — $5 →

Want just the food side first? The Protein Playbook covers hitting your protein target on a suppressed appetite for $1.

The single best home signal: strength over time

If you track one thing, track your strength. It is free, it is specific, and it is the outcome that actually matters. Pick a few basic movements, a squat or a sit-to-stand, a push, a pull, and a carry, and record what you can do every week or two: the weight, the reps, or how many repetitions before it gets hard. Rising or steady strength at a lower body weight is strong evidence you are keeping muscle. A clear, sustained decline over several weeks, not a single off day, is the signal to change something.

What you change is well established. In a meta-analysis of older adults losing weight through caloric restriction, adding resistance training offset about 93.5 percent of the lean-mass loss that dieting alone would have cost.4 And a dose-response meta-analysis found that protein intake up to about 1.6 grams per kilogram of body weight per day improved training results, roughly double the standard 0.8 g/kg dietary reference intake.5 Training and protein are the two levers, and they are the same two the appetite suppression works against.

When to talk to a clinician

This article is educational and cannot diagnose you. Bring it to your clinician if you notice a lasting drop in strength or function, if everyday tasks like climbing stairs or rising from the floor become harder, if you feel unusually weak, unsteady, or fatigued, or if you have lost weight much faster than expected. Older adults begin with less muscle in reserve, and longer-term data in older adults points to strength declines beyond mass alone,3 so the threshold to ask is lower. Your clinician can examine you, consider other causes, and order a body-composition scan if it is warranted. Do not change your medication or dose on your own.

The bottom line

Some lean-mass loss comes with any large, fast weight loss, and a GLP-1 produces exactly that. The scale will not tell you what left, and even a DXA number is only part of the picture, so the most reliable thing you can do is watch your own strength over time and pay attention when familiar effort starts feeling harder. Muscle is also the reserve you carry into the day you come off the medication: about two-thirds of lost weight returned within a year of stopping semaglutide in the STEP 1 extension,9 which is exactly why the muscle you protect now is worth the attention. If the signs point one way, the answer is not to stop losing weight; it is to add resistance training and protein so the weight you lose is the weight you meant to lose.

Frequently asked

How can I tell if I'm losing muscle or just fat on a GLP-1?

No single measurement is definitive, so watch several signals together. The scale cannot separate fat from muscle, and even a DXA lean-mass reading includes water and organ tissue. The most practical home signal is your own strength over time: if the same movements get noticeably harder at a lower body weight, and you are eating little protein and doing no resistance training, that combination is worth taking seriously. Reviews place lean mass at roughly 15 to 40 percent of total GLP-1 weight lost.

Does feeling weaker on Ozempic or Wegovy mean I'm losing muscle?

Not on its own. Fatigue and feeling weaker can come from eating far less, dehydration, low energy during dose increases, or poor sleep, none of which are muscle loss by themselves. Short-term GLP-1 trials often showed preserved grip strength even as lean mass fell. The clearer sign is a sustained drop in what you can actually lift or carry over several weeks, not a single tired day. If weakness is new, persistent, or severe, contact your clinician.

When should I talk to my doctor about muscle loss on a GLP-1?

This article is educational and not a diagnosis. Talk to your clinician if you notice a lasting drop in strength or function, if everyday tasks like climbing stairs or getting up from the floor become harder, if you feel unusually weak or unsteady, or if you are an older adult, since longer-term data in older adults points to strength declines beyond mass alone. Your clinician can assess you and, where appropriate, order a body-composition scan.

References

  1. Neeland IJ, et al. Changes in lean body mass with established and emerging GLP-1-based therapies and mitigation strategies. Diabetes, Obesity & Metabolism. 2024. doi.org/10.1111/dom.15728
  2. Look M, et al. Body composition changes during weight reduction with tirzepatide (SURMOUNT-1 DXA substudy). Diabetes, Obesity & Metabolism. 2025. pmc.ncbi.nlm.nih.gov/articles/PMC11965027
  3. Prokopidis K. Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: risks beyond muscle mass reductions. British Journal of Pharmacology. 2026. pubmed.ncbi.nlm.nih.gov/41577337
  4. Sardeli AV, et al. Resistance training prevents muscle loss induced by caloric restriction in obese elderly: a systematic review and meta-analysis. Nutrients. 2018;10(4):423. mdpi.com/2072-6643/10/4/423
  5. Morton RW, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance-training-induced gains. British Journal of Sports Medicine. 2018. pmc.ncbi.nlm.nih.gov/articles/PMC5867436
  6. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021. pubmed.ncbi.nlm.nih.gov/33567185
  7. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022. pubmed.ncbi.nlm.nih.gov/35658024
  8. Investigating nutrient intake during use of GLP-1 receptor agonist: cross-sectional study. Frontiers in Nutrition. 2025. frontiersin.org
  9. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity & Metabolism. 2022. pmc.ncbi.nlm.nih.gov/articles/PMC9542252